InvestorsHub Logo
Followers 52
Posts 3348
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Monday, 01/27/2020 5:05:34 PM

Monday, January 27, 2020 5:05:34 PM

Post# of 3283
I have to walk my last post back some. I just checked Amgen's 3rd Q earnings and their Neulasta sales was $619M so Rolontis would only get $215M/yr sales w 10% of the market. Amgen should come out w new earnings this week and we'll see if Neulasta sales went down some more.